Journal article
Treatment of adult rhabdoid renal cell carcinoma with sorafenib
Abstract
Renal cell carcinoma (RCC) with rhabdoid features is an uncommon and highly aggressive malignancy. We report a case of adult clear-cell RCC with extensive rhabdoid features treated with the tyrosine kinase inhibitor sorafenib. A review of the literature summarizes important aspects of this malignancy. We discuss clinical and histological findings as well as the patient's response to sorafenib therapy.
Authors
Kapoor A; Tutino R; Kanaroglou A; Hotte SJ
Journal
Canadian Urological Association Journal, Vol. 2, No. 6,
Publisher
Canadian Urological Association Journal
Publication Date
December 2008
DOI
10.5489/cuaj.983
ISSN
1911-6470